Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.72 USD | -1.32% | -0.15% | -20.28% |
May. 16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.28% | 413M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+50.24% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Replimune, Roche to Collaborate on Cancer Drug Development Program